On June 17, 2021, Guangzhou Boji Medical & Biotechnological Co., Ltd. closed the transaction. The company has issued 33,450,584 Shares at a price of CNY 10.26 per share for gross proceeds of CNY 343,202,991.84 in the transaction. The company has incurred issuance costs of CNY 6,786,273.95 and received net proceeds of CNY 336,416,717.89 in the transaction. The transaction included participation from Guangzhou High-tech Investment Group Co., Ltd. suscribing 8,771,929 shares for CNY 89,999,991.54, Caitong Fund Management Co., Ltd. subscribing 2,274,853 shares for CNY 23,339,991.78, Fu'an Commerce and Trade (Jiangmen) Co., Ltd. subscribing 974,658 shares for CNY 9,999,991.08, Maoming Dongxin Property Real Estate Development Co., Ltd. subscribing 974,658 shares for CNY 9,999,991.08, Beijing Yiren Capital Management Co., Ltd. subscribing 974,658 shares for CNY 9,999,991.08, Gongqingcheng Yinyi Investment Partnership Enterprise (L.P.) subscribing 2,436,647 shares for CNY 24,999,998.22, Gongqingcheng Yinchi Investment Partnership Enterprise (L.P.) subscribing 2,436,647 shares for CNY 24,999,998.22, Guangzhou Ruisheng Private Securities Investment Management Partnership Enterprise (L.P.)-Ruisheng 8, a fund managed by Guangzhou Ruisheng Equity Investment Co., Ltd. subscribing 5,542,209 shares for CNY 56,863,064.34, Yu Wenbin suscribing 5,653,021 shares for CNY 57,999,995.46, Huang Qingwen subscribing 1,461,988 shares for CNY 14,999,996.88, Zheng Fuhua subscribing 974,658 shares for CNY 9,999,991.08, and Yu Zhenhuan subscribing 974,658 shares for CNY 9,999,991.08.